Jacob Hurd

Duke Medical Center, Harvard University

Papers

2

Total Citations

108

H-Index

2

About

Jacob Hurd is a leading thoracic surgeon and researcher whose work focuses on optimizing surgical outcomes for thymic malignancies, particularly thymoma and thymic carcinoma. His major contributions center on large-scale, national database analyses comparing open versus minimally invasive thymectomy techniques. Hurd’s landmark 2019 study, cited 83 times, provided critical evidence on the safety and efficacy of video-assisted thoracoscopic and robotic approaches for stage I–III thymoma, demonstrating comparable oncologic outcomes with reduced morbidity. He extended this work in a 2022 analysis of thymic carcinoma, a rarer and more aggressive tumor, where his findings helped clarify the role of minimally invasive surgery in this challenging population. By leveraging the National Cancer Database, Hurd has produced high-impact, real-world evidence that directly informs clinical decision-making. His research is widely cited by surgeons and oncologists seeking to balance radical resection with quality of life. Hurd’s work has been instrumental in advancing the adoption of minimally invasive techniques for thymic tumors, making him a key voice in thoracic surgical oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
108
Total Citations
54
Avg Citations/Paper
🏆 Most Cited Paper
A national analysis of open versus minimally invasive thymectomy for stage I to III thymoma
83 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Duke Medical Center, Harvard University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago